Patient-Centered Management of Dyslipidemia: Part 2 Guidelines Pocket Guide - Guideline Central

Patient-Centered Management of Dyslipidemia: Part 2

National Lipid AssociationPublished: July 11, 2016

A PDF version of this Pocket Guide is also available!
$13.95
  • Key Points 
  • Lifestyle 
  • General Management 
  • Hypertriglyceridemia 
  • Children and Adolescents 
  • Special Populations 
    • Women’s Health 
    • Older Patients 
    • Ethnic Groups 
    • Concurrent Conditions 
  • Residual Risk After Statins and Lifestyle Modification 
  • Charts 
    • Nutritional Recommendations 
    • Exercise/Physical Activity Recommendations 
    • Patient Adherence 
    • Team-Based Collaborative Care 
  • Figures 
    • Clinical Algorithm for Screening and Management of Elevated TG 
    • Dyslipidemia Algorithm Targeting LDL-C from the 2011 Expert Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents 
    • Statin Combination Therapy 
  • Tables 
    • Criteria for ASCVD Risk Assessment, Treatment Goals for Atherogenic Cholesterol, and Levels at Which to Consider Drug Therapy 
    • Changes from Baseline Lipoprotein Lipid Levels by Diet in Omniheart 
    • Predicted Effects of Macronutrient Replacement of Dietary Saturated Fatty Acids with PUFA, MUFA, and Carbohydrate on Lipoprotein Lipids Based on Results from Controlled Feeding Trials 
    • Evaluation of Hypertriglyceridemia 
    • Nutrition Therapy for Very High TG (≥500 mg/dL)/Chylomicron Clearing 
    • Acceptable, Borderline-high, and High Plasma Lipoprotein Lipids and Apolipoprotein Concentrations for Children and Adolescents 
    • Major Risk Factors and Conditions in Children and Adolescents 
    • International Diabetes Federation’s Definition of the At Risk Group and Metabolic Syndrome in Children and Adolescents 
    • Lipid Lowering Agents and Pregnancy Categories 
    • Criteria for Diagnosis of PCOS
    • Interactions Between ART and Statins
    • RA Treatments with Manufacturer Package Inserts Recommending Frequency of Lipid Measurements
    • Significant Risk Indicators 
    • Recommendations 
    • Statin Combination Therapies (Clinical trial results) 

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.